000			01705 a2200457 4500
005			20250518083755.0
264		0	_c20201027
008			202010s 0 0 eng d
022			_a1090-2430
024	7		_a10.1016/j.expneurol.2020.113222 _2doi
040			_aNLM _beng _cNLM
100	1		_aAida, Virginia
245	0	0	_aAcute administration of perampanel, an AMPA receptor antagonist, reduces cognitive impairments after traumatic brain injury in rats. _h[electronic resource]
260			_bExperimental neurology _c05 2020
300			_a113222 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBrain Injuries, Traumatic _xcomplications
650	0	4	_aCognition _xdrug effects
650	0	4	_aCognitive Dysfunction _xdrug therapy
650	0	4	_aDisease Models, Animal
650	0	4	_aExcitatory Amino Acid Antagonists _xpharmacology
650	0	4	_aHippocampus _xdrug effects
650	0	4	_aMale
650	0	4	_aMaze Learning _xdrug effects
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aNitriles
650	0	4	_aPyridones _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptors, AMPA _xantagonists & inhibitors
650	0	4	_aSpatial Memory _xdrug effects
650	0	4	_aTreatment Outcome
650	0	4	_abcl-2-Associated X Protein _xmetabolism
650	0	4	_abcl-X Protein _xmetabolism
700	1		_aNiedzielko, Tracy L
700	1		_aSzaflarski, Jerzy P
700	1		_aFloyd, Candace L
773	0		_tExperimental neurology _gvol. 327 _gp. 113222
856	4	0	_uhttps://doi.org/10.1016/j.expneurol.2020.113222 _zAvailable from publisher's website
999			_c30604902 _d30604902